Cite
MLA Citation
T H Yiu et al.. “P564 vedolizumab versus infliximab and adalimumab in the real-world persistence in Ulcerative Colitis and Crohn's disease – a meta-analysis.” Journal of Crohn's and colitis, vol. 17, n.d., pp. i694–i695. http://access.bl.uk/ark:/81055/vdc_100179843701.0x000012